MoneyWorks4Me

Hester Biosciences - Quaterly Results

16 May 2026 Evaluate
The company witnessed a 22.23% growth in the revenue at Rs. 937.13 millions for the quarter ended March 2026 as compared to Rs. 766.72 millions during the year-ago period.The Total revenue for the quarter ended March 2026 of  Rs. 263.84  millions  grew by 173.83% from Rs. 96.35 millions.Operating profit for the quarter ended March 2026 rose to 356.44 millions as compared to 147.60 millions of corresponding quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 937.13 766.72 22.23 2921.36 2864.66 1.98 2921.36 2864.66 1.98
Other Income 41.79 10.58 294.99 76.35 47.64 60.26 76.35 47.64 60.26
PBIDT 356.44 147.60 141.49 801.07 557.08 43.80 801.07 557.08 43.80
Interest 40.94 12.49 227.78 71.69 53.67 33.58 71.69 53.67 33.58
PBDT 385.46 135.11 185.29 799.34 503.41 58.79 799.34 503.41 58.79
Depreciation 36.76 20.28 81.26 102.52 85.81 19.47 102.52 85.81 19.47
PBT 348.70 114.83 203.67 696.82 417.60 66.86 696.82 417.60 66.86
TAX 84.86 18.48 359.20 175.82 99.18 77.27 175.82 99.18 77.27
Deferred Tax 7.62 -18.23 -141.80 31.16 -13.52 -330.47 31.16 -13.52 -330.47
PAT 263.84 96.35 173.83 521.00 318.42 63.62 521.00 318.42 63.62
Equity 85.07 85.07 0.00 85.07 85.07 0.00 85.07 85.07 0.00
PBIDTM(%) 38.04 19.25 97.58 27.42 19.45 41.01 27.42 19.45 41.01
Peers
Company Name CMP
Sun Pharma. Inds. 1850.80
Dr. Reddys Labs. 1210.80
Cipla 1374.50
Lupin 2095.55
Zydus Lifesciences 1161.35
View more..